본문 바로가기
KERD
논문KCI 등재

An Update on [18F]Fluoride PET Imaging for Atherosclerotic Disease

석주원|이리리
한국지질동맥경화학회 (The Korean Society of Lipidology and Atherosclerosis)|2020.09|지질·동맥경화학회지 (Journal of Lipid and Atherosclerosis)|제9권 제3호|pp. 349-361|DOI 10.12997/jla.2020.9.3.349

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

PET-CTAtherosclerosisSodium fluoridePositron emission tomography

초록

Atherosclerosis is the leading cause of life-threatening morbidity and mortality, as the rupture of atherosclerotic plaques leads to critical atherothrombotic events such as myocardial infarction and ischemic stroke, which are the 2 most common causes of death worldwide. Vascular calcification is a complicated pathological process involved in atherosclerosis, and microcalcifications are presumed to increase the likelihood of plaque rupture. Despite many efforts to develop novel non-invasive diagnostic modalities, diagnostic techniques are still limited, especially before symptomatic presentation. From this point of view, vulnerable plaques are a direct target of atherosclerosis imaging. Anatomic imaging modalities have the limitation of only visualizing macroscopic structural changes, which occurs in later stages of disease, while molecular imaging modalities are able to detect microscopic processes and microcalcifications, which occur early in the disease process. Na[18F]-fluoride positron emission tomography/computed tomography could allow the early detection of plaque instability, which is deemed to be a primary goal in the prevention of cardiac or brain ischemic events, by quantifying the microcalcifications within vulnerable plaques and evaluating the atherosclerotic disease burden.

Abstract

Atherosclerosis is the leading cause of life-threatening morbidity and mortality, as the rupture of atherosclerotic plaques leads to critical atherothrombotic events such as myocardial infarction and ischemic stroke, which are the 2 most common causes of death worldwide. Vascular calcification is a complicated pathological process involved in atherosclerosis, and microcalcifications are presumed to increase the likelihood of plaque rupture. Despite many efforts to develop novel non-invasive diagnostic modalities, diagnostic techniques are still limited, especially before symptomatic presentation. From this point of view, vulnerable plaques are a direct target of atherosclerosis imaging. Anatomic imaging modalities have the limitation of only visualizing macroscopic structural changes, which occurs in later stages of disease, while molecular imaging modalities are able to detect microscopic processes and microcalcifications, which occur early in the disease process. Na[18F]-fluoride positron emission tomography/computed tomography could allow the early detection of plaque instability, which is deemed to be a primary goal in the prevention of cardiac or brain ischemic events, by quantifying the microcalcifications within vulnerable plaques and evaluating the atherosclerotic disease burden.

참고문헌 (84)

  1. Heron M, "Deaths : leading causes for 2010", Natl Vital Stat Rep, 62, pp.1~96 (2013)
  2. Benjamin EJ, "Heart disease and stroke statistics-2019 update : a report from the American Heart Association", Circulation, 139, pp.e56~e528 (2019)
  3. Demer LL, "Mineral exploration : search for the mechanism of vascular calcification and beyond : the 2003 Jeffrey M. Hoeg Award lecture", Arterioscler Thromb Vasc Biol, 23, pp.1739~1743 (2003)
  4. Johnson RC, "Vascular calcification : pathobiological mechanisms and clinical implications", Circ Res, 99, pp.1044~1059 (2006)
  5. Wu M, "Vascular calcification : an update on mechanisms and challenges in treatment", Calcif Tissue Int, 93, pp.365~373 (2013)
  6. Dweck MR, "Coronary arterial 18F-sodium fluoride uptake : a novel marker of plaque biology", J Am Coll Cardiol, 59, pp.1539~1548 (2012)
  7. Kataoka Y, "Spotty calcification as a marker of accelerated progression of coronary atherosclerosis : insights from serial intravascular ultrasound", J Am Coll Cardiol, 59, pp.1592~1597 (2012)
  8. Vengrenyuk Y, "A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps", Proc Natl Acad Sci U S A, 103, pp.14678~14683 (2006)
  9. Ehara S, "Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction : an intravascular ultrasound study", Circulation, 110, pp.3424~3429 (2004)
  10. McEvoy JW, "Coronary artery calcium progression: an important clinical measurement? A review of published reports", J Am Coll Cardiol, 56, pp.1613~1622 (2010)
  11. Ueda M, "Clinical relevance of coronary artery calcification, as a risk factor for plaque rupture : viewpoint from pathology", Clin Calcium, 20, pp.1656~1662 (2010)
  12. Kelly-Arnold A, "Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries", Proc Natl Acad Sci U S A, 110, pp.10741~10746 (2013)
  13. Osborn EA, "Imaging atherosclerosis and risk of plaque rupture", Curr Atheroscler Rep, 15, pp.359~ (2013)
  14. Moghbel M, "The role of PET in evaluating atherosclerosis : a critical review", Semin Nucl Med, 48, pp.488~497 (2018)
  15. Falk E, "Pathogenesis of atherosclerosis", J Am Coll Cardiol, 47, pp.C7~C12 (2006)
  16. Schaar JA, "Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece", Eur Heart J, 25, pp.1077~1082 (2004)
  17. Tarkin JM, "PET imaging of inflammation in atherosclerosis", Nat Rev Cardiol, 11, pp.443~457 (2014)
  18. Motoyama S, "Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome", J Am Coll Cardiol, 54, pp.49~57 (2009)
  19. Cai J, "In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque : comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology", Circulation, 112, pp.3437~3444 (2005)
  20. Obaid DR, "Atherosclerotic plaque composition and classification identified by coronary computed tomography : assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology", Circ Cardiovasc Imaging, 6, pp.655~664 (2013)
  21. Andrews JPM, "New methods to image unstable atherosclerotic plaques", Atherosclerosis, 272, pp.118~128 (2018)
  22. -fluorodeoxyglucose positron emission tomography, "Circulation", 2002, 2708~2711
  23. 김정민, "Analysis of 18F-Fluorodeoxyglucose and 18F-Fluoride Positron Emission Tomography in Korean Stroke Patients with Carotid Atherosclerosis", 지질·동맥경화학회지, 8(2), pp.232~241 (2019), 한국지질동맥경화학회[DOI]
  24. Tawakol A, "In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients", J Am Coll Cardiol, 48, pp.1818~1824 (2006)
  25. -fluorodeoxyglucose positron emission tomography(FDG-PET), "Eur J Vasc Endovasc Surg", 2009, 714~721
  26. Paulmier B, "Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events", J Nucl Cardiol, 15, pp.209~217 (2008)
  27. Figueroa AL, "Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features : a comparison between positron emission tomography activity, plaque morphology, and histopathology", Circ Cardiovasc Imaging, 5, pp.69~77 (2012)
  28. Figueroa AL, "Measurement of arterial activity on routine FDG PET", CT images improves prediction of risk of future CV events, 2013, pp.6, 1250~1259
  29. Kelly PJ, "Carotid plaque inflammation imaged by 18F-fluorodeoxyglucose positron emission tomography and risk of early recurrent stroke", Stroke, 50, pp.1766~1773 (2019)
  30. Rose S, "A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET", CT : a pilot study, 2013, pp.3, 273~278
  31. Naik HB, "Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET", CT and neutrophil activation in a prospective observational study, 2015, pp.35, 2667~2676
  32. Li X, "68Ga-DOTATATE PET", CT for the detection of inflammation of large arteries : correlation with18F-FDG, calcium burden and risk factors, 2012, pp.2, 52~
  33. Malmberg C, "64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors : head-to-head comparison with 68Ga-DOTATOC in 60 patients", J Nucl Med, 56, pp.1895~1900 (2015)
  34. Rominger A, "In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET", CT : correlation with coronary calcium burden and risk factors, 2010, pp.51, 193~197
  35. 이리리, "Measurement of 68Ga-DOTATOC Uptake in the Thoracic Aorta and Its Correlation with Cardiovascular Risk", Nuclear Medicine and Molecular Imaging, 52(4), pp.279~286 (2018), 대한핵의학회
  36. FDG PET imaging, "J Am Coll Cardiol", 2017, 1774~1791
  37. Bucerius J, "Feasibility of 18F-fluoromethylcholine PET", CT for imaging of vessel wall alterations in humans--first results, 2008, pp.35, 815~820
  38. PK 11195, "Atherosclerosis", 2008, 108~111
  39. -PK11195 and positron emission tomography, "computed tomography angiography", J Am Coll Cardiol, 56, pp.653~661 (2010)
  40. Gaemperli O, "Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography", computed tomography, 2012, pp.33, 1902~1910
  41. Joshi FR, "Vascular imaging with 18F-fluorodeoxyglucose positron emission tomography is influenced by hypoxia", J Am Coll Cardiol, 69, pp.1873~1874 (2017)
  42. Blau M, "18 F-fluoride for bone imaging", Semin Nucl Med, 2, pp.31~37 (1972)
  43. Hawkins RA, "Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET", J Nucl Med, 33, pp.633~642 (1992)
  44. Czernin J, "Molecular mechanisms of bone 18F-NaF deposition", J Nucl Med, 51, pp.1826~1829 (2010)
  45. Creager MD, "18F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission tomography", computed tomography images, 2019, pp.12, e007835~
  46. Irkle A, "Identifying active vascular microcalcification by(18)F-sodium fluoride positron emission tomography", Nat Commun, 6, pp.7495~ (2015)
  47. Vesey AT, "18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor ischemic stroke : case-control study", Circ Cardiovasc Imaging, 10, pp.e004976~ (2017)
  48. Stary HC, "Natural history of calcium deposits in atherosclerosis progression and regression", Z Kardiol, 89(Suppl 2), pp.28~35 (2000)
  49. Ritman EL, "Small-animal CT-its difference from, and impact on, clinical CT", Nucl Instrum Methods Phys Res A, 580, pp.968~970 (2007)
  50. Derlin T, "Feasibility of 18F-sodium fluoride PET", CT for imaging of atherosclerotic plaque, 2010, pp.51, 862~865
  51. Li Y, "Association of vascular fluoride uptake with vascular calcification and coronary artery disease", Nucl Med Commun, 33, pp.14~20 (2012)
  52. Fiz F, "18F-NaF uptake by atherosclerotic plaque on PET", CT imaging : inverse correlation between calcification density and mineral metabolic activity, 2015, pp.56, 1019~1023
  53. Quirce R, "Contribution of 18F-sodium fluoride PET", CT to the study of the carotid atheroma calcification, 2013, pp.32, 22~25
  54. Quirce R, "New insight of functional molecular imaging into the atheroma biology : 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results", Clin Physiol Funct Imaging, 36, pp.499~503 (2016)
  55. Kitagawa T, "18F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis", Atherosclerosis, 263, pp.385~392 (2017)
  56. Joshi NV, "18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques : a prospective clinical trial", Lancet, 383, pp.705~713 (2014)
  57. -NaF positron emission tomography on culprit carotid atherosclerosis : a prospective study, "JACC Cardiovasc Imaging", 2019, 370~372
  58. Lee JM, "Clinical relevance of 18F-sodium fluoride positron-emission tomography in noninvasive identification of high-risk plaque in patients with coronary artery disease", Circ Cardiovasc Imaging, 10, pp.e006704~ (2017)
  59. Li L, "Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease : a cross-correlation study with intravascular ultrasound", Eur J Nucl Med Mol Imaging, 45, pp.2181~2189 (2018)
  60. Youn T, "18F-sodium fluoride positron emission tomography", computed tomography in ex vivo human coronary arteries with histological correlation, 2020, pp.40, 404~411
  61. Fiz F, "Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk", World J Radiol, 8, pp.82~89 (2016)
  62. Beheshti M, "Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography", computed tomography--a novel concept, 2011, pp.14, 114~120
  63. Blomberg BA, "Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk : results of the CAMONA study", Eur J Nucl Med Mol Imaging, 44, pp.249~258 (2017)
  64. Arani LS, "Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta", Hell J Nucl Med, 22, pp.14~19 (2019)
  65. Ryoo HG, "Clinical implication of 18F-NaF PET", computed tomography indexes of aortic calcification in coronary artery disease patients : correlations with cardiovascular risk factors, 2020, pp.41, 58~64
  66. Yahagi K, "Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus", Arterioscler Thromb Vasc Biol, 37, pp.191~204 (2017)
  67. Meyer PW, "Rheumatoid arthritis and risk of cardiovascular disease", Cardiovasc J Afr, 29, pp.317~321 (2018)
  68. Seraj SM, "Assessing the feasibility of NaF-PET", CT versus FDG-PET, Ann Nucl Med, pp.2020, 34[DOI]
  69. Hedgire S, "Perivascular epicardial fat stranding at coronary CT angiography : a marker of acute plaque rupture and spontaneous coronary artery dissection", Radiology, 287, pp.808~815 (2018)
  70. Margaritis M, "Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels", Circulation, 127, pp.2209~2221 (2013)
  71. Marwan M, "CT attenuation of pericoronary adipose tissue in normal versus atherosclerotic coronary segments as defined by intravascular ultrasound", J Comput Assist Tomogr, 41, pp.762~767 (2017)
  72. Kwiecinski J, "Peri-coronary adipose tissue density is associated with 18F-sodium fluoride coronary uptake in stable patients with high-risk plaques", JACC Cardiovasc Imaging, 12, pp.2000~2010 (2019)
  73. Yerramasu A, "Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis", Atherosclerosis, 220, pp.223~230 (2012)
  74. Oka T, "Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography", Int J Cardiol, 161, pp.45~49 (2012)
  75. Kitagawa T, "Relationship between coronary arterial 18F-sodium fluoride uptake and epicardial adipose tissue analyzed using computed tomography", Eur J Nucl Med Mol Imaging, 47, pp.1746~1756 (2020)
  76. Janssen T, "Association of linear 18F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors : a PET", CT study, 2013, pp.20, 569~577
  77. Chowdhury MM, "Vascular positron emission tomography and restenosis in symptomatic peripheral arterial disease : a prospective clinical study", JACC Cardiovasc Imaging, 13, pp.1008~1017 (2020)
  78. Moss AJ, "Ticagrelor to reduce myocardial injury in patients with high-risk coronary artery plaque", JACC Cardiovasc Imaging, 13, pp.1549~1560 (2020)
  79. Zwakenberg SR, "The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes : a randomized, double-blind, placebo-controlled trial", Am J Clin Nutr, 110, pp.883~890 (2019)
  80. Alavi A, "PET-based imaging to detect and characterize cardiovascular disorders : unavoidable path for the foreseeable future", J Nucl Cardiol, 25, pp.203~207 (2018)
  81. Alavi A, "What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques", J Nucl Cardiol, 25, pp.2012~2015 (2018)
  82. Blomberg BA, "Coronary fluorine-18-sodium fluoride uptake is increased in healthy adults with an unfavorable cardiovascular risk profile : results from the CAMONA study", Nucl Med Commun, 38, pp.1007~1014 (2017)
  83. Sorci O, "18F-sodium fluoride PET", CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification, 2020, pp.47, 1678~1687
  84. Kwiecinski J, "Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden", Eur J Nucl Med Mol Imaging, 47, pp.1736~1745 (2020)

관련 논문AI추천

Multimodality Imaging in Coronary Artery Disease: Focus on Computed Tomography이지현, 한동희, Bríain ó Hartaigh, Fay Y. Lin, Ibrahim Danad, James K. Min한국심초음파학회 · Journal of Cardiovascular Imaging2016 · 제24권 제1호Analysis of 18F-Fluorodeoxyglucose and 18F-Fluoride Positron Emission Tomography in Korean Stroke Patients with Carotid Atherosclerosis권오상, 김정민, 박광열, 석주원, 이은성한국지질동맥경화학회 · 지질·동맥경화학회지2019 · 제8권 제2호Diagnostic and Therapeutic Approach of Carotid and Cerebrovascular Plaque on the Basis of Vessel Imaging박종호, 이동현한국지질동맥경화학회 · 지질·동맥경화학회지2017 · 제6권 제1호Targeted Theranostic Strategy for Atherosclerotic Plaques Using Intravascular Multimodal Imaging TechniquesKim Jin Hyuk, Kim Jin Won, Park Kyeongsoon, Yoo Hongki한국지질동맥경화학회 · 지질·동맥경화학회지2025 · 제14권 제3호Roles of Vascular Smooth Muscle Cells in Atherosclerotic Calcification김대용, 우상호, 최재훈한국지질동맥경화학회 · 지질·동맥경화학회지2023 · 제12권 제2호Complementarity between 18F-FDG PET/CT and Ultrasonography or Angiography in Carotid Plaque Characterization강병택, 김동억, 노상미, 여정석, 이동근, 정상욱, 최원준, Dawid Schellingerhout대한신경과학회 · Journal of Clinical Neurology2013 · 제9권 제3호

이 간행물의 다른 논문 (10건)

Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to TreatmentRiekelt H. Houtkooper, Ronald J.A. Wanders, Gepke Visser, Sacha Ferdinandusse, Frédéric M. Vazpp. 313-333Are Persistent Organic Pollutants Linked to Lipid Abnormalities, Atherosclerosis and Cardiovascular Disease? A ReviewP. Monica Lind, Lars Lindpp. 334-348Clinical Benefit of Statins in Korean Patients with Acute Myocardial Infarction: Experience of the Korea Acute Myocardial Infarction Registry정명호, 조경훈pp. 362-379Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine ModelsMakoto Taniguchi, Toshiro Okazakipp. 380-405REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy박수진, 박동호pp. 406-418
원문 보기